Tag: Ozempic
Semaglutide Dosing Errors Driving Surge in Poison Control Calls, Study Shows
Poison control centres are reporting a surge in calls related to semaglutide (Ozempic, Wegovy) following the drug's approval for weight…
GLP-1 Drugs Linked to Lower Violent Behaviour in Rutgers Study
Rutgers University researchers found an association between GLP-1 receptor agonists (Ozempic, Wegovy) and weakened impulsivity-violence links in observational analysis. The…
Most People Who Stop GLP-1 Drugs Like Ozempic Eventually Return to Treatment
A new analysis of treatment patterns shows that many patients who discontinue GLP-1 receptor agonists for type 2 diabetes eventually…
GLP-1 Weight Loss Drugs Linked to Reduced Physical Activity Despite Weight Loss Success
New research analyzing Fitbit data reveals that people taking GLP-1 weight loss drugs experience declining physical activity levels despite successful…
GLP-1 Drugs Show 30% Lower Breast Cancer Risk in Major Study
Large observational study finds women taking GLP-1 drugs like Ozempic and Wegovy show 30% lower breast cancer rates. Clinical trials…
Scientists Discover Why Ozempic and Wegovy Weight Loss Plateaus After Initial Success
NIH scientists have discovered why GLP-1 weight-loss medications like Ozempic and Wegovy eventually plateau, with 47% of patients experiencing reduced…
GLP-1 Drugs Like Ozempic Cut Heart Attack Risk by 20% in Major Review
Major international review finds GLP-1 drugs like Ozempic reduce heart attack risk by 20% and stroke risk by 18%. The…